CN108025077A - 经皮递送系统 - Google Patents

经皮递送系统 Download PDF

Info

Publication number
CN108025077A
CN108025077A CN201680054263.8A CN201680054263A CN108025077A CN 108025077 A CN108025077 A CN 108025077A CN 201680054263 A CN201680054263 A CN 201680054263A CN 108025077 A CN108025077 A CN 108025077A
Authority
CN
China
Prior art keywords
hours
dihydroetorphine
less
mean
plasma concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201680054263.8A
Other languages
English (en)
Chinese (zh)
Inventor
史蒂夫·怀特洛克
德博拉·菲莉丝·哈丁
海伦·约翰逊
凯文·史密斯
吉尔·蒙蒂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euro Celtique SA
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of CN108025077A publication Critical patent/CN108025077A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CN201680054263.8A 2015-07-30 2016-07-28 经皮递送系统 Pending CN108025077A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1513441.4 2015-07-30
GBGB1513441.4A GB201513441D0 (en) 2015-07-30 2015-07-30 Transdermal delivery system
PCT/GB2016/052307 WO2017017452A1 (en) 2015-07-30 2016-07-28 Transdermal delivery system

Publications (1)

Publication Number Publication Date
CN108025077A true CN108025077A (zh) 2018-05-11

Family

ID=54062902

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201680054263.8A Pending CN108025077A (zh) 2015-07-30 2016-07-28 经皮递送系统

Country Status (16)

Country Link
US (1) US20180221299A1 (https=)
EP (1) EP3328431A1 (https=)
JP (1) JP2018528175A (https=)
KR (1) KR20180035859A (https=)
CN (1) CN108025077A (https=)
AR (1) AR105533A1 (https=)
AU (1) AU2016298761A1 (https=)
BR (1) BR112018001615A2 (https=)
CA (1) CA2994103A1 (https=)
GB (1) GB201513441D0 (https=)
IL (1) IL256995A (https=)
MA (1) MA42521A (https=)
MX (1) MX2018001318A (https=)
SG (1) SG10201913254RA (https=)
TW (1) TW201713340A (https=)
WO (1) WO2017017452A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10231248A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk ジヒドロエトルフィン含有経皮吸収型製剤
CN104119349A (zh) * 2008-12-08 2014-10-29 欧洲凯尔特公司 二氢埃托啡及其制备

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
KR101159828B1 (ko) * 2003-04-30 2012-07-04 퍼듀 퍼머 엘피 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10231248A (ja) * 1997-02-19 1998-09-02 T T S Gijutsu Kenkyusho:Kk ジヒドロエトルフィン含有経皮吸収型製剤
CN104119349A (zh) * 2008-12-08 2014-10-29 欧洲凯尔特公司 二氢埃托啡及其制备

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
SATOSHI OHMORI等: "Transdermal Delivery of the Potent Analgesic Dihydroetorphine: Kinetic Analysis of Skin Permeation and Analgesic Effect in the Hairless Rat", 《J. PHARM. PHARMACOL》 *
郭庆东，等: "介质pH，药物浓度，月桂氮酮对二氢埃托啡透皮(蛇皮)作用的影响", 《中国药学杂志》 *
陈小平，等: "二氢埃托啡透皮给药系统的研究", 《药学学报》 *

Also Published As

Publication number Publication date
MX2018001318A (es) 2018-08-15
WO2017017452A1 (en) 2017-02-02
JP2018528175A (ja) 2018-09-27
TW201713340A (zh) 2017-04-16
CA2994103A1 (en) 2017-02-02
GB201513441D0 (en) 2015-09-16
SG10201913254RA (en) 2020-03-30
EP3328431A1 (en) 2018-06-06
AU2016298761A1 (en) 2018-02-15
BR112018001615A2 (pt) 2018-09-18
IL256995A (en) 2018-03-29
US20180221299A1 (en) 2018-08-09
AR105533A1 (es) 2017-10-11
MA42521A (fr) 2018-06-06
KR20180035859A (ko) 2018-04-06

Similar Documents

Publication Publication Date Title
JP6212104B2 (ja) オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑止性経皮製剤
US10729686B2 (en) Pharmaceutical compositions
CN101146523B (zh) 透皮给药系统
TW201338813A (zh) 經皮遞送系統
Gupta et al. Transdermal delivery: product and patent update
TW201521796A (zh) 用於經皮傳遞三級胺藥物之組合物及方法
TW201817419A (zh) 用於處理疼痛之右美托咪啶經皮遞送裝置
US20190328681A1 (en) Transdermal patch
NO331441B1 (no) Transdermal granistetron
JP6600658B2 (ja) 日に１回の取り替えによるフェンタニルの経皮投与
KR20080042769A (ko) 구역에 대한 경피 방법 및 패치
US20070248657A1 (en) Multi-compartment transdermal pain control device
CN101155578A (zh) 采用药物组合治疗的方法以及适合于该方法的药物组合
JP2010514789A (ja) 副腎皮質ステロイド投与のための経皮的方法及びパッチ
CN108025077A (zh) 经皮递送系统
US20060223786A1 (en) Transdermal pain control method and device
JP6793718B2 (ja) 経皮送達系
DE102006011340A1 (de) Wirkstoffhaltige Pflaster mit verbesserter Handhabung

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20180511

WD01 Invention patent application deemed withdrawn after publication